[Federal Register Volume 60, Number 21 (Wednesday, February 1, 1995)]
[Notices]
[Page 6141]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-2374]



[[Page 6141]]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the National 
Institute on Drug Abuse (NIDA) advisory committee meetings.
    These meetings will be open to the public as indicated below with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the contact person in 
advance of the meeting.
    Ms. Camilla L. Holland, NIDA Committee Management Officer, National 
Institutes of Health, Parklawn Building, Room 10-42, 5600 Fishers Lane, 
Rockville, MD 20857, (301) 443-2755, will provide summaries of the 
meetings and rosters of committee members upon request. Substantive 
program information may be obtained from the contacts listed below.

Committee Name: National Advisory Council on Drug Abuse
Meeting Date: February 7-8, 1995
Place:
    February 7, National Institutes of Health, Building 31, Conference 
Room 10, 9000 Rockville Pike, Bethesda, MD 20892
    February 8, Parklawn Building, Conference, Room G, 5600 Fishers 
Lane, Rockville, MD 20857
Open: February 7, 1995, 9 a.m.-5 p.m.
Agenda: Administrative, legislative, and program development reports
Closed: February 8, 1995, 9 a.m. to adjournment
Agenda: Review and evaluation of grant applications
Contact: Eleanor C. Friedenberg, Executive Secretary, Parklawn 
Building, Room 10-42, 5600 Fishers Lane, Rockville, MD 20857, Telephone 
(301) 443-2755

Committee Name: Drug Abuse Biomedical Research Review Committee
Meeting Date: February 13, 1995
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, MD 
20814
Open: February 13, 8:30 a.m. to 9:30 a.m.
Agenda: Presentation by the Director, NIDA
Contact: Gamil Debbas, Ph.D., Scientific Review Administrator, Parklawn 
Building, Room 10-42, 5600 Fishers Lane, Rockville, MD 20857, Telephone 
(301) 443-2620

Committee Name: Biochemistry Research Subcommittee, Drug Abuse 
Biomedical Research Review Committee
Meeting Date: February 13-15, 1995
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, MD 
20814
Closed: 12 Noon
Agenda: Review and evaluation of grant applications
Contact: Rita Liu, Ph.D., Scientific Review Administrator, Parklawn 
Building, Room 10-42, 5600 Fishers Lane, Rockville, MD 20857, Telephone 
(301) 443-2620

Committee Name: Pharmacology I Research Subcommittee, Drug Abuse 
Biomedical Research Review Committee
Meeting Date: February 13-15, 1995
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, MD 
20814
Closed: 9:30 a.m.
Agenda: Review and evaluation of grant applications
Contact: Syed Husain, Ph.D., Scientific Review Administrator, Parklawn 
Building, Room 10-42, 5600 Fishers Lane, Rockville, MD 20857, Telephone 
(301) 443-2620

Committee name: Pharmacology II Research Subcommittee, Drug Abuse 
Biomedical Research Review Committee
Meeting Date: February 13-15, 1995
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, MD 
20814
Closed: 9:30 a.m.
Agenda: Review and evaluation of grant applications
Contact: Gamil Debbas, Ph.D., Scientific Review Administrator, Parklawn 
Building, Room 10-42, 5600 Fishers Lane, Rockville, MD 20857, Telephone 
(301) 443-2620.

Committee name: Drug Abuse Epidemiology and Prevention Research Review 
Committee
Meeting Date: February 14-15, 1995
Place: Ramada Inn, Rockville, 1775 Rockville Pike, Rockville, MD 20852
Open: February 14, 8:30 a.m. to 9:30 a.m.
Agenda: Presentation by the Director, NIDA
Closed: 9:30 a.m.
Agenda: Review and evaluation of grant applications
Contact: Raquel Crider, Ph.D., Scientific Review Administrator, 
Parklawn Building, Room 10-22, 5600 Fishers Lane, Rockville, MD 20857, 
Telephone (301) 443-9042.

    These meetings will be closed in accordance with provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. Applications 
and the discussions could reveal confidential trade secrets or 
commercial property such as patentable material and personal 
information concerning individuals associated with the applications, 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.
    This notice is being published less than fifteen days prior to the 
meeting due to the urgent need to meet timing limitations imposed by 
the grant review cycle.

(Catalog of Federal Domestic Assistance Program Numbers: 93.277, 
Drug Abuse Research Scientist Development and Research Scientist 
Awards; 93.278, Drug Abuse National Research Service Awards for 
Research Training; 93.279, Drug Abuse Research Programs)

    Dated: January 25, 1995.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 95-2374 Filed 1-31-95; 8:45 am]
BILLING CODE 4140-01-M